$21.70
0.693.28%
Last update: Nov 6, 5:39 PM
uniQure NV (QURE) Stock Price, Quote, News & History
QURENASDAQ
uniQure (NASDAQ:QURE) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of uniQure (NASDAQ:QURE) through any online brokerage.
Other companies in uniQure’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
uniQure has a consensus price target of $53.75.
The stock price for uniQure (NASDAQ: QURE) is $22 last updated November 6, 2026 at 5:39 PM EST.
There are no upcoming dividends for uniQure.
uniQure does not have any upcoming earnings scheduled.
There is no upcoming split for uniQure.
uniQure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The...
